chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a 64 year old male patient with no drug reactions/allergies, who on 06-NOV-2008 was vaccinated subcutaneously with a 0.5 mL dose of ZOSTAVAX (Merck) (Lot #663197/1418X).  There was no concomitant medication.  On 10-NOV-2008 the patient developed an "itchy rash on the back of his neck".  The patient was seen by the physician and the rash encompassed the right side of the neck and scalp.  The physician did not wish to culture the rash.  At the time of reporting, the patient was recovering.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 12/23/2008. Follow up information received from a physician on 05-JAN-2008. It was reported that concomitant therapy included COLESTID, ACCUPRIL, aspirin, METAMUCIL, folic acid, ezetimibe (+) simvastatin and ascorbic acid. On 11-NOV-2008 the patient noted a vesicular rash on the right side neck and post scalp with minor discomfort. Patient was treated with FAVIA and then the patient recovered. Additional information is not expected.
swollen lymph nodes in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph nodes in the left arm) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2012, the patient experienced LYMPHADENOPATHY (swollen lymph nodes in the left arm). At the time of the report, LYMPHADENOPATHY (swollen lymph nodes in the left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitants were reported. No treatment was reported.
Information has been received from a licensed practical nurse who is the mother of an approximately 11 year old female child with no past medical history, who in approximately 1993 or 1994 was vaccinated with the third dose of hepatitis B vaccine recombinant (yeast). There was no concomitant medication and no known allergies. The mother reported that starting the next day, following vaccination, the child began having headaches, which became more severe as time went on. She also experienced aches and pains all over her body and missed almost a year of school. It was also reported that the child sleeps poorly and is losing her eyesight. At the time of this report, the child continued to experience the aches and pains. The mother reported that the child use to be a very active, healthy child until she had the vaccination. She has been to numerous doctors over the years. The mother also reported that about one week after vaccination was given, she found out the child had received a recalled lot of vaccine. The child is reported to be still doing poorly. Upon internal review, the events of blindness, headaches and pain were considered to be other important medical events. Additional information has been requested.
no adverse event; vaccine administered after temperature excursion; This spontaneous report was received from a medical assistant, concerning a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medication, and previous drug reactions or allergies.  On 27-SEP-2021, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection (SQ), at a dose of 0.5 milliliter (ml) (lot number U015689, which was verified to be a valid lot number, expiration date reported as 13-MAY-2023 but upon internal validation established as 18-MAY-2023), as prophylaxis (frequency, route of administration, anatomical location and vaccination scheme were not reported). The vaccine was administered after a temperature excursion of 25.9 F during a time frame of 1 hour and 30 minutes (product storage error). There was not a previous temperature excursion. No adverse events were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2110USA000932: US-009507513-2110USA001023:
been tired he had lack of energy problems; been tired he had lack of energy problems; problem sleeping; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received BNT162b2 (BNT162B2), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer.), for COVID-19 Immunization. The following information was reported: FATIGUE (non-serious), outcome "not recovered", ASTHENIA (non-serious), outcome "unknown" and all described as "been tired he had lack of energy problems"; SLEEP DISORDER (non-serious), outcome "unknown", described as "problem sleeping".  Additional information: Patient asked if problems to sleep have been reported as a side effect of the Pfizer-BioNTech COVID-19 vaccine booster and how long this side effect may last. Patient stated that, he got his first booster of the Pfizer-BioNTech COVID-19 vaccine. He been tired he had lack of energy problems. Ever since he got the booster, he had a problem sleeping. After this, he ain't getting the second booster dose. Patient was asking how long his fatigue will last.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
(per pt's description) "Severe cold symptoms, worst cold ever! Very Congested, very painful throat, couldn't talk. Bronchitis for 10 days (I was perfectly healthy before I received the vaccine) the vacceine made me very sick"  (HCP decription) - pt came in and wanted a vaers report filled out. I copied her description into this box. Pt said she was getting over her cold and was doing better. She said she had not come into contact with anyone who was sick.
1 hour after vaccination L arm and neck were numb, L axillary lymph node swollen
Very sick; Nauseated; Fever for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Very sick), NAUSEA (Nauseated) and PYREXIA (Fever for 3 days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (Very sick), NAUSEA (Nauseated) and PYREXIA (Fever for 3 days). At the time of the report, ILLNESS (Very sick) and NAUSEA (Nauseated) outcome was unknown and PYREXIA (Fever for 3 days) had resolved.            No relevant concomitant medications were reported. Treatment information was unknown.
Pt recvd HIB vax & 2 months following vax pt had devel small nodule @ inject site;
9/9/03 HAD LESS THAN 10 RASHY AREAS,SEEN BY PHYSICIAN NO FEVER (HAD FEVER THE WEEK OF 8/25/03) GIVEN BENADRYL FOR ALLERGIES BY PHYSICIAN 9/23 AWAKENED THAT TIME WITH HUNDREDS OF BLISTER LESIONS IN VARIOUS STAGES OF DEVELOPMENT-SEEN BY PHYSICIAN AND DIAGNOSED WITH CHICKENPOX, AT THAT TIME CHILD HAD TEMP OF 100.4 AND WAS FEELING ILL. FEELING ILL
32 yo male with PMH of TBI, OSA, insomnia, migraine, irriitability and anger, obesity, abnormal LFTs, chronic back pain, and PTSD reported having injection site pain, diarrhea, fatigue, body aches, dizziness after his first dose of pfizer covid-19 vaccine on 2/17/2021. He took tylenol and eletriptan for headaches but did not resolve. Pt went to the ED on 2/20/21 and tested positive for covid-19. Pt reported this ADR on 3/10/2021, when he completed this second dose of covid-19 vaccine. Headache, Fever, Diarrhea, NauseaVomiting &fatigue, generalized aches and pain, injection site pain
Severe arm pain, dizziness, nausea, vomiting, fever, chills, shakes, headache Inability to move arm (movement now restored but very painful)
29 y/o female, past medical history of HTN (unmedicated) and Arrythmia (type unknown), who presents with left facial, neck and left upper extremity numbness onset set shortly after vaccination. Patient states that this is her 1st dose in the two-dose series, and she has never had a reaction to vaccinations in the past. NP and Paramedics at patient side. Water was provided to patient and legs elevated. Patient facial features symmetrical with no facial droop, equal strength and pulses to the upper extremities. Stroke scale negative. Patient also states a weird iron like taste to her mouth, a very strong taste but states that she can swallow without difficulty. Patient noted to be Hypertensive (155/103 R) on initial vitals, all other vitals within normal limits. Repeat vitals showed that patient remained Hypertensive (156/91, 145/103, 158/106, 160/84). Patient was then moved (ambulated to the gurney) and placed behind the partitions for privacy. At this time, EKG was performed with NSR. Patient stated that the numbness to her left arm and neck had resolved but remained with the iron taste to her mouth and slight numbness to her left cheek. Repeat EKG was performed and showed an Arrythmia (per Paramedics). At this time, due to elevated BP and facial numbness Fire Rescue was notified via Police Officer on detail. Hialeah Fire Rescue arrived at the site and assessed patient on the truck. Per Fire Rescue, it was noted on EKG that patient in AFib. Patient declined transport to the ER for further evaluation and signed Against Medical Advice with Fire Rescue and as well with Logistics team and Healthcare workers. Patient was ambulated to her car with the NP at her side. NP advise patient to seek further medical evaluation due to her risk of stroke, worsening arrythmia leading to cardiac event and/or possible death. NP also advise patient to obtain a primary care provider and cardiologist to address her Hypertension and Arrythmia. Patient verbalized understanding.
Fever night 103-104 degrees, tired.  Continued fever >24 hours 104.4.
Passed out 30 seconds p/vax;then had shaking all over then woke up;
Patient told prior that did not like vaccines and have delayed covid vaccine awhile due to having problems in vaccine in general. Patient seems to faint but conscious and had a seizure type of reaction. 911 was called and patient was ok.
Left deltoid, red, raised, itchy, size of a 50 cent piece.  Gave patient Benadryl oral and applied ice.
Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19) in an elderly patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In October 2022, the patient experienced COVID-19 (Covid-19). At the time of the report, COVID-19 (Covid-19) had resolved.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication information were provided. Patient had COVID-19 disease by the end of Oct2022 after receiving COVID-19 vaccine on 22Sep2022.   This case was linked to US-MODERNATX, INC.-MOD-2023-735421 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-735421:Patient 1
A report received from a health professional on 10/22/2002, concerning a 5 month old male vaccinee who inadvertently received the Fluvirin vaccine on 10/18/2001. The vaccinee experienced no adverse event. There was insufficient information to determine the reporter's causality assessment.
Sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore left arm) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 062E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Aug-2021, the patient experienced PAIN IN EXTREMITY (Sore left arm). At the time of the report, PAIN IN EXTREMITY (Sore left arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications were reported.  Treatment information was not provided.   This case was linked to MOD-2021-411865, MOD-2021-410277 (Patient Link).
Stated with shakes had fever around 7pm on 03/05/2002. Face was swollen, hands and arm a bit swollen. Temp of 102.5 degrees F was told to go to the hospital. At temp 102.9, the pt was given coritizon thru IV Zantac. Temp went down and was released. Pt stated that his heart was racing about 114 while sitting/not moving at all. After he was released from the hospital, pt fever came back and he was feeling fatigued all day. But was returned to work on 03/07/2002 still feeling a bit fatigued.
4hr p/vax pt listless & pale;sent to ER; in ER had 20min staring episode;hosp for r/o sz;
This report describes the occurrence of inflammatory arthritis in a 46 year old male who was vaccinated with Lyme disease vaccine recombinant (Lymerix) for prophylaxis. This report was received as part of litigation proceedings and has not been verified by a physician or other health care professional. The subject's medical history, concurrent conditions, and concurrent medications were not provided. The subject's attorney alleged that on or about Aug 30,2000 various marketing campaigns based directly upon the representations contained in those advertising campaigns (the subject) sought and received vaccinations on Dec 17,1999 adn Jan 18, 2000. Thereafter (he) experienced chronic recurring fatigue, peripheral neuropathy and inflammatory arthritis. As such (he) has been left to suffer with what has thus far been incurable and at times debilitating pain which, severely limited his employment options and opportunities. The Lymerix immunizations series was discontinued.
FEVER OF 101.0F AS WELL AS RUNNY NOSE, SNIFFLING, SNEEZING. PROGRESSED TO COUGHING AS NIGHT WENT ON, RESTLESS, CAN NOT SLEEP DUE TO COUGH AND FEVER.
itches; chills; fever; aches; I have a rash where the injection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 04Nov2021 17:30 (Lot number: FG3527) at the age of 45 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Known allergies: Penicillin" (unspecified if ongoing). Concomitant medication(s) included: ALLEGRA D. The following information was reported: PRURITUS (non-serious) with onset 04Nov2021, outcome "recovering", described as "itches"; CHILLS (non-serious) with onset 04Nov2021, outcome "recovering", described as "chills"; PYREXIA (non-serious) with onset 04Nov2021, outcome "recovering", described as "fever"; PAIN (non-serious) with onset 04Nov2021, outcome "recovering", described as "aches"; VACCINATION SITE RASH (non-serious) with onset 04Nov2021, outcome "recovering", described as "I have a rash where the injection". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pruritus, chills, pyrexia, pain, vaccination site rash.  Additional Information: The patient did not received any other vaccines within 4 weeks prior to the covid 19 vaccine. The patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. adverse event: I had chills fever aches all the night after I had shot I have a rash where the injection was and it itches and is hard to touch  No follow-up attempts are possible. No further information is expected.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Oct2022 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 70 years for COVID-19 immunisation; COVID-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Osteoporosis" (unspecified if ongoing); "Pre-diabetes" (unspecified if ongoing); "High cholesterol" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Mar2023, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Mar2023) Negative, notes: for 3 days after last dose of Paxlovid; (Mar2023) Positive, notes: on day 5. Therapeutic measures were taken as a result of drug ineffective, COVID-19 with Paxlovid from 09Mar2023 to 14Mar2023.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Itching to site 11 days after vaccine. Noted 10cm area of redness, warmth and swelling of the site in the evening of the 11th day. Took Zyrtec and applied steorid cream.
Inflammation and tingling in head, pressure in head and neck, confusion, mild psychosis, distorted senses, chronic fatigue, symptoms lasted 2 1/2 months. Treatment Bed rest and Fluids. 12/15/06-Records reviewed-DC DX for DOS 7/15-7/21/06 AXIS I:Psychotic disorder, not otherwise specified R/O Psychosis secondary to medical condition. AXIS II: Deferred AXIS III: Rule out viral meningitis, rule out sinusitis AXIS IV: None AXIS V: GAF: 50 C/O increased insomnia, racing thoughts, hearing sounds
Nausea; Vomiting; Fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), VOMITING (Vomiting) and PYREXIA (Fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea), VOMITING (Vomiting) and PYREXIA (Fever). At the time of the report, NAUSEA (Nausea), VOMITING (Vomiting) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Ear pain, pressure and fullness in both ears, but left side worse. Constant ringing in both ears. Dizziness and nausea. 10 days of antibiotics and Sudafed, 5 days of prednisone, and multiple days of allergy medications have not worked or helped alleviate symptoms.
16 yo F received vaccination had a syncopal event in observation. She recovered immediately. She has had a history of similar reactions in the past.
Pain in joints of left hand  beginning day after vaccination lasting 2 days; describes severe pain for 2 days - currently improving
Fever up to 102 on and off for 4 days, chills for 4 days, nausea is still on going, vomiting, vertigo is still on going, sensitivity to light and sound for 2 days. Body aches and pains for 4 days consistently but now it?s lightened up but hasn?t gone away completely. I?m going to contact my doctor if the symptoms doing go away by tomorrow. It?s Sunday so their office is closed.
Pt. stated appx. 16 hours after injection the injection site on right arm became swollen, red, hot and tender to touch.  Pt. states he massaged the injection under warm water and used a warm compress to affected area off and on for 6-8 hours.  Next he placed ice packs on injection site for appx. 30 minutes every 4-6 hours.  Pt. took no medications as he was directed at time of injection.  Pt. has NKDA. circumference of upper arms was Right upper bicep 43.0 cm mid bicep 40.0 cm lower bicep 35.5cm erythema vertical 20 inches horizontal 24 inches left upper bicep 39.0 cm left mid bicep 37.0 cm left lower bicep32.5 cm Pt. was instructed by physician to take motrin every 6-8 hours, apply ice packs for 30 min. every 4-6 hours and apply corticaid cream as needed not to exceed twice a day.  If condition shows no signs of improvement in 48 hours to seek follow up with provider.
Vomited twice at 7pm day of injections. Decreased energy level. Following morning 9/16 awoke with hives covering most of body. (R) thigh has largest hive. 9/17 hives worsening. BENADRYL being given every 4hrs. ZYRTEC initiated 9/16.
Sore, swollen, hot itchy for 72 hours after vaccine received. Redness around injection site size of baseball.
hives, heart palipitations, Diarhea, nausea, vertigo, severe pain in lower left quadrent of abdomen, low grade fever between 99.6-100. , ear pain, parched, and more. These were all symptoms I had at the beginning of covid in Sept 2020. They ALL came back full force for 17 days. I am a few days out from second vaccine and am terrified to go through this again.
Narrative:  COVID infection following COVID vaccine series 12/29/2020, Pfizer, dose #1 01/19/2021, Pfizer, dose #2 08/11 pt cc: cough, diarrhea, fatigue, fever, rhinorrhea , myalgias, chills exposure: unknown 08/12- 09/03 pt symptoms continue 08/12 admit to ED dx: COVID 19 and acute diverticulitis LOC 1 day 08/12 09/02 COVID swab, result: detected 08/12 ESR result: 19 08/12 CXR Impression: Lung hyperinflation may be secondary to vigorous inspiratory effort versus air trapping, otherwise, no radiographic evidence of acute cardiopulmonary disease. 08/12 SARS-COV-2 LINEAGE B.1.617.2 08/12 SARS-COV-2 CLADE 21A DELTA 08/20 clinically resolved 09/02 COVID swab, result: detected